<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03950440</url>
  </required_header>
  <id_info>
    <org_study_id>S61710</org_study_id>
    <nct_id>NCT03950440</nct_id>
  </id_info>
  <brief_title>Assessing the Incidence of Postoperative Delirium Following Aortic Valve Replacement</brief_title>
  <acronym>IPOD-AV</acronym>
  <official_title>Assessing the Incidence of Postoperative Delirium Following Aortic Valve Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our primary aim in this observational study is to identify the incidence of POD in the first&#xD;
      five postoperative days by using the 3-minute Diagnostic confusion assessment method&#xD;
      (3D-CAM), the derived version for intensive care unit (CAM-ICU) or nurse reports in patients&#xD;
      undergoing different techniques of aortic valve replacement. Patients are followed 5 days&#xD;
      postoperative with the 3D-CAM or until resolution of POD. Six months postoperatively, a&#xD;
      follow-up by phone is planned for activity of daily living (ADL).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A significant and often underrecognized complication after surgery is postoperative delirium&#xD;
      (POD) causing increased morbidity and mortality. This is especially true for the older&#xD;
      cardiac surgical patient, in whom the incidence of POD is up to 70%. Surgical invasiveness&#xD;
      and herewith related inflammation, a cholinergic load of medications, postoperative pain or&#xD;
      use of opioids are examples of precipitating factors that can be altered to reduce the&#xD;
      incidence of POD. Transaortic valve replacement (TAVR) is a revolutionary technique that has&#xD;
      led to a dramatic decrease in surgical invasiveness and improved outcomes in high-risk&#xD;
      surgical patients. However, only a few studies evaluated neurocognitive outcome after&#xD;
      surgical aortic valve replacement (SAVR) compared to TAVR, suggesting a reduced incidence of&#xD;
      POD with TAVR compared to SAVR. In contrast, other studies found almost no difference in POD&#xD;
      in the aforementioned patient groups. Hence, it remains still unclear which technique best to&#xD;
      use in patients at high risk for POD.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 23, 2018</start_date>
  <completion_date type="Actual">July 9, 2020</completion_date>
  <primary_completion_date type="Actual">January 20, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of postoperative delirium</measure>
    <time_frame>During the first five postoperative days or until discharge, in case of POD followup until resolution of POD or discharge.</time_frame>
    <description>Using the 3-minute Diagnostic confusion assessment method (3D-CAM), the derived version for intensive care unit (CAM-ICU) or nurse reports combined with interview with the caregivers and patient</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Onset postoperative delirium</measure>
    <time_frame>During the first five postoperative days or discharge</time_frame>
    <description>Moment of onset of POD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of POD</measure>
    <time_frame>If POD develops during the first 5 postoperative days, patient will be followed until POD has resolved or until discharge</time_frame>
    <description>Duration of delirium in days using the 3D-CAM or ICU-CAM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of POD</measure>
    <time_frame>If POD develops during the first 5 postoperative days, patient will be followed until POD has resolved or until discharge</time_frame>
    <description>assessed with the delirium severity measure-based CAM (CAM-S Long)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early safety according to VARC-2</measure>
    <time_frame>30 days</time_frame>
    <description>Early safety (at 30 days) defined by the Valve Academic Research Consortium (VARC)-2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical efficacy according to VARC-2</measure>
    <time_frame>6 months</time_frame>
    <description>Clinical efficacy (at 6 months) as defined by VARC-2</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Intensive care unit (ICU) length of stay</measure>
    <time_frame>30 days</time_frame>
    <description>Intensive care unit (ICU) length of stay</description>
  </other_outcome>
  <other_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>30 days</time_frame>
    <description>Amount of days hospitalized in the primary center</description>
  </other_outcome>
  <other_outcome>
    <measure>Discharge destination</measure>
    <time_frame>30 days</time_frame>
    <description>Discharge destination defined as: home, nursing home, revalidation unit or other hospital.</description>
  </other_outcome>
  <other_outcome>
    <measure>6-months interview</measure>
    <time_frame>6 months</time_frame>
    <description>Assessment of different questionnaires: self-administered instrumental activities of daily living, 5 dimensional quality of life (EQ-5D-5L), visual analoge scale for quality of life (EQ-VAS) and cognitive failure questionnaire.</description>
  </other_outcome>
  <enrollment type="Actual">250</enrollment>
  <condition>Postoperative Delirium</condition>
  <condition>Aortic Valve Stenosis</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      presence of neural injury markers&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Any patient presenting for the indicated surgery in a tertiary university hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients scheduled to undergo elective&#xD;
&#xD;
               -  TAVI&#xD;
&#xD;
               -  SAVR (with or without coronary artery bypass grafting (CABG) or pulmonary vein&#xD;
                  isolation (PVI))&#xD;
&#xD;
          -  Patient able to read and understand the research materials&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to give informed consent&#xD;
&#xD;
          -  Presence of delirium at baseline as screened with the 3-minute Diagnostic Confusion&#xD;
             Assessment Method (3D-CAM)&#xD;
&#xD;
          -  Combined surgical procedures (e.g. mitral valve surgery, aortic surgery or other)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Danny Hoogma, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitaire Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospitals Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>May 8, 2019</study_first_submitted>
  <study_first_submitted_qc>May 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2019</study_first_posted>
  <last_update_submitted>January 13, 2021</last_update_submitted>
  <last_update_submitted_qc>January 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitaire Ziekenhuizen Leuven</investigator_affiliation>
    <investigator_full_name>dr. Danny Hoogma</investigator_full_name>
    <investigator_title>Anesthesiologist</investigator_title>
  </responsible_party>
  <keyword>Transaortic valve replacement</keyword>
  <keyword>Surgical aortic valve replacement</keyword>
  <keyword>TAVR</keyword>
  <keyword>SAVR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 13, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/40/NCT03950440/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

